Trial intelligence / Profile preview

Medication and Case Management for ADHD in Children

NCT02142140Unknown

Sponsor
McGill University Health Centre
Start
Dec 2012
Primary completion
Feb 2019
Countries
1
01

Overview

Randomised, open-label trial in attention deficit hyperactivity disorder (ADHD) (2 arms), sponsored by McGill University Health Centre. Primary endpoint: Attention Deficit Hyperactivity Disorder symptomatology at 27 months. Status: unknown.

02

Conditions

attention deficit hyperactivity disorder (ADHD)

Beyond the preview

Go deeper on NCT02142140.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02142140.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call